Segall Bryant & Hamill’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q4 | – | Sell |
-18,602
| Closed | -$1.85M | – | 879 |
|
2019
Q3 | $1.85M | Sell |
18,602
-400
| -2% | -$39.7K | 0.03% | 420 |
|
2019
Q2 | $1.76M | Buy |
19,002
+2,859
| +18% | +$264K | 0.03% | 431 |
|
2019
Q1 | $1.52M | Sell |
16,143
-13,956
| -46% | -$1.32M | 0.02% | 459 |
|
2018
Q4 | $1.93M | Sell |
30,099
-4,373
| -13% | -$280K | 0.03% | 410 |
|
2018
Q3 | $3.09M | Sell |
34,472
-2,763
| -7% | -$247K | 0.05% | 365 |
|
2018
Q2 | $2.96M | Buy |
37,235
+8,447
| +29% | +$671K | 0.05% | 379 |
|
2018
Q1 | $2.57M | Sell |
28,788
-440
| -2% | -$39.3K | 0.06% | 279 |
|
2017
Q4 | $3.05M | Sell |
29,228
-4,087
| -12% | -$426K | 0.07% | 265 |
|
2017
Q3 | $4.86M | Buy |
33,315
+17,441
| +110% | +$2.54M | 0.11% | 197 |
|
2017
Q2 | $2.06M | Sell |
15,874
-208
| -1% | -$27K | 0.05% | 304 |
|
2017
Q1 | $2M | Buy |
16,082
+243
| +2% | +$30.2K | 0.05% | 298 |
|
2016
Q4 | $1.83M | Buy |
15,839
+175
| +1% | +$20.3K | 0.05% | 300 |
|
2016
Q3 | $1.64M | Sell |
15,664
-450
| -3% | -$47K | 0.04% | 313 |
|
2016
Q2 | $1.59M | Buy |
16,114
+340
| +2% | +$33.5K | 0.04% | 312 |
|
2016
Q1 | $1.58M | Buy |
15,774
+600
| +4% | +$60.1K | 0.04% | 320 |
|
2015
Q4 | $1.82M | Hold |
15,174
| – | – | 0.04% | 298 |
|
2015
Q3 | $1.64M | Sell |
15,174
-100
| -0.7% | -$10.8K | 0.04% | 314 |
|
2015
Q2 | $1.77M | Hold |
15,274
| – | – | 0.04% | 317 |
|
2015
Q1 | $1.76M | Sell |
15,274
-1,340
| -8% | -$154K | 0.04% | 308 |
|
2014
Q4 | $1.86M | Hold |
16,614
| – | – | 0.04% | 308 |
|
2014
Q3 | $1.58M | Buy |
16,614
+1,400
| +9% | +$133K | 0.04% | 319 |
|
2014
Q2 | $1.31M | Sell |
15,214
-274
| -2% | -$23.5K | 0.03% | 289 |
|
2014
Q1 | $1.08M | Sell |
15,488
-230
| -1% | -$16.1K | 0.03% | 321 |
|
2013
Q4 | $1.33M | Sell |
15,718
-2,200
| -12% | -$186K | 0.03% | 305 |
|
2013
Q3 | $1.38M | Buy |
17,918
+5,856
| +49% | +$451K | 0.03% | 302 |
|
2013
Q2 | $706K | Buy |
+12,062
| New | +$706K | 0.02% | 342 |
|